Palbociclib Hydrochloride, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Palbociclib Hydrochloride - API Standards [catalogue_number] => PA 16 3010000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 484 [form] => C24H30ClN7O2 [cas] => 827022-32-2 [pslug] => 827022-32-2-palbociclib-hydrochloride-api-pa163010000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 16 3010000
CAS :
Molecular Formula : C24H30ClN7O2
Molecular Weight : 484
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
